Well, first we need to see if it is a problem and if so, how bad. Certain cholesterol medications can cause liver problems, but not for everyone, which is why they monitor it. As Cindy mentioned, it's not so horrible that it was pulled from study. However, it bears watching and it may affect some patients. The other question is if 661 should pan out, are those of us that would need 2 medications at higher risk for liver complications?